NCT01122030View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 19, 2010

Primary Completion Date

February 23, 2011

Study Completion Date

March 22, 2011

Conditions
Opioid Induced Bowel Dysfunction
Interventions
DRUG

Naldemedine

Tablets or solution for oral administration

DRUG

Placebo

Tablets or solution for oral administration

Trial Locations (1)

84106

Shionogi Research Site, Salt Lake City

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY